No, Massachusetts, you can’t run a PBM-style Medicaid formulary, feds sayAllbiopro2018-07-04T22:47:42+09:007월 4th, 2018|
Amgen, Novartis ‘overwhelmed’ by early interest in migraine drug Aimovig: expertAllbiopro2018-07-04T22:47:18+09:007월 4th, 2018|
Sen. Patty Murray calls out BIO, PhRMA on gender diversity effortsAllbiopro2018-07-04T22:46:30+09:007월 4th, 2018|
Cash-strapped Titan delays Parkinson’s implant programAllbiopro2018-07-04T22:46:07+09:007월 4th, 2018|
Antibe builds case for GI safety of naproxen alternativeAllbiopro2018-07-04T22:45:20+09:007월 4th, 2018|
FDA Seeks Injunctions in Fight Against $2.4bn Unapproved Stem Cell MarketAllbiopro2018-07-04T22:44:33+09:007월 4th, 2018|
Biogen to Increase Stake in Samsung Bioepis Joint Venture for $700 MillionAllbiopro2018-07-04T22:43:45+09:007월 4th, 2018|
Novartis to Spinoff Alcon Eye Care Device Biz and Initiates $5-Billion Share BuybackAllbiopro2018-07-04T22:43:21+09:007월 4th, 2018|
Sustainable business – Sartorius signs the United Nations Global CompactAllbiopro2018-07-03T23:52:08+09:007월 3rd, 2018|
Pfizer chastised for missing risks in pharma ad police’s second letter of 2018Allbiopro2018-07-03T12:04:37+09:007월 3rd, 2018|
UK’s National Health Service scrambles to prepare for ‘hard Brexit’Allbiopro2018-07-03T12:04:13+09:007월 3rd, 2018|
CVC Capital revs up rare disease ambitions with $3.5B Recordati buyoutAllbiopro2018-07-03T12:03:49+09:007월 3rd, 2018|
Roche eyes next-generation breast cancer crown with Tecentriq’s triple-negative victoryAllbiopro2018-07-03T12:03:25+09:007월 3rd, 2018|
Look out, EpiPen. With Adamis deal, Novartis is gunning for your salesAllbiopro2018-07-03T12:03:00+09:007월 3rd, 2018|
